314 related articles for article (PubMed ID: 2104880)
1. Neuropeptide Y and peptide YY inhibit lipolysis in human and dog fat cells through a pertussis toxin-sensitive G protein.
Valet P; Berlan M; Beauville M; Crampes F; Montastruc JL; Lafontan M
J Clin Invest; 1990 Jan; 85(1):291-5. PubMed ID: 2104880
[TBL] [Abstract][Full Text] [Related]
2. Human fat cell lipolysis is primarily regulated by inhibitory modulators acting through distinct mechanisms.
Kather H; Bieger W; Michel G; Aktories K; Jakobs KH
J Clin Invest; 1985 Oct; 76(4):1559-65. PubMed ID: 2997284
[TBL] [Abstract][Full Text] [Related]
3. Identification and functional studies of a specific peptide YY-preferring receptor in dog adipocytes.
Castan I; Valet P; Voisin T; Quideau N; Laburthe M; Lafontan M
Endocrinology; 1992 Oct; 131(4):1970-6. PubMed ID: 1327725
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase in bovine adrenal chromaffin cells via a pertussis toxin-sensitive process.
Zhu J; Li W; Toews ML; Hexum TD
J Pharmacol Exp Ther; 1992 Dec; 263(3):1479-86. PubMed ID: 1335068
[TBL] [Abstract][Full Text] [Related]
5. Peptide-YY and neuropeptide-Y inhibit vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate production in rat small intestine: structural requirements of peptides for interacting with peptide-YY-preferring receptors.
Servin AL; Rouyer-Fessard C; Balasubramaniam A; Saint Pierre S; Laburthe M
Endocrinology; 1989 Feb; 124(2):692-700. PubMed ID: 2536315
[TBL] [Abstract][Full Text] [Related]
6. [Adrenergic lipolysis in human fat cells: properties and physiological role of alpha-adrenergic receptors (author's transl)].
Berlan M; Lafontan M; Dang Tran L
J Physiol (Paris); 1980; 76(2):133-46. PubMed ID: 6249915
[TBL] [Abstract][Full Text] [Related]
7. Functional and molecular properties of the human recombinant Y4 receptor: resistance to agonist-promoted desensitization.
Voisin T; Goumain M; Lorinet AM; Maoret JJ; Laburthe M
J Pharmacol Exp Ther; 2000 Feb; 292(2):638-46. PubMed ID: 10640301
[TBL] [Abstract][Full Text] [Related]
8. Actions of peptide YY and neuropeptide Y on chief cells from guinea pig stomach.
Raufman JP; Singh L
Am J Physiol; 1991 Jun; 260(6 Pt 1):G820-6. PubMed ID: 1647673
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptides, including neuropeptide Y and melanocortins, mediate lipolysis in murine adipocytes.
Bradley RL; Mansfield JP; Maratos-Flier E
Obes Res; 2005 Apr; 13(4):653-61. PubMed ID: 15897473
[TBL] [Abstract][Full Text] [Related]
10. Effects of adenosine and pertussis toxin on lipolysis in adipocytes from exercise-trained male rats.
Shinoda S; Izawa T; Komabayashi T; Suda K; Tsuboi M; Iwane H
Res Commun Chem Pathol Pharmacol; 1989 Dec; 66(3):397-410. PubMed ID: 2609017
[TBL] [Abstract][Full Text] [Related]
11. Lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462.
Saulnier-Blache JS; Taouis M; Dauzats M; Uzan A; Berlan M; Lafontan M
J Pharmacol Exp Ther; 1989 Dec; 251(3):1187-92. PubMed ID: 2574742
[TBL] [Abstract][Full Text] [Related]
12. Alpha-2 adrenergic antilipolytic effect in dog fat cells: incidence of obesity and adipose tissue localization.
Berlan M; Carpene C; Lafontan M; Dang-Tran L
Horm Metab Res; 1982 May; 14(5):257-60. PubMed ID: 6284627
[TBL] [Abstract][Full Text] [Related]
13. Characterization of functional neuropeptide Y receptors in a human neuroblastoma cell line.
Gordon EA; Kohout TA; Fishman PH
J Neurochem; 1990 Aug; 55(2):506-13. PubMed ID: 2164571
[TBL] [Abstract][Full Text] [Related]
14. Lack of desensitization of alpha-2-mediated inhibition of lipolysis in fat cells after acute and chronic treatment with clonidine.
Villeneuve A; Carpene C; Berlan M; Lafontan M
J Pharmacol Exp Ther; 1985 May; 233(2):433-40. PubMed ID: 2987483
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo impairment of alpha2-adrenergic receptor-dependent antilipolysis by fatty acids in human adipose tissue.
Gesta S; Hejnova J; Berlan M; Daviaud D; Crampes F; Stich V; Valet P; Saulnier-Blache JS
Horm Metab Res; 2001 Dec; 33(12):701-7. PubMed ID: 11753754
[TBL] [Abstract][Full Text] [Related]
16. Adrenergic regulation of human fat-cell lipolysis.
Kather H
Horm Metab Res Suppl; 1988; 19():40-3. PubMed ID: 3235058
[TBL] [Abstract][Full Text] [Related]
17. Peptide YY antagonizes beta-adrenergic-stimulated release of insulin in dogs.
Greeley GH; Lluis F; Gomez G; Ishizuka J; Holland B; Thompson JC
Am J Physiol; 1988 Apr; 254(4 Pt 1):E513-7. PubMed ID: 2895586
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of isoproterenol-induced lipolysis in rat inguinal adipocytes in vitro by physiological melatonin via a receptor-mediated mechanism.
Zalatan F; Krause JA; Blask DE
Endocrinology; 2001 Sep; 142(9):3783-90. PubMed ID: 11517154
[TBL] [Abstract][Full Text] [Related]
19. Leptin-induced lipolysis opposes the tonic inhibition of endogenous adenosine in white adipocytes.
Frühbeck G; Gómez-Ambrosi J; Salvador J
FASEB J; 2001 Feb; 15(2):333-40. PubMed ID: 11156949
[TBL] [Abstract][Full Text] [Related]
20. A1-adenosine receptor-mediated inhibition of adipocyte adenylate cyclase and lipolysis in Zucker rats.
Vannucci SJ; Klim CM; Martin LF; LaNoue KF
Am J Physiol; 1989 Dec; 257(6 Pt 1):E871-8. PubMed ID: 2558574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
